As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of DNA X, Inc. The largest reported stake is DNA Holdings Venture Inc.'s, at 19.9%. 16 filings are on record since July 2, 2025 (Schedule 13D, February 20, 2026).
Sell to companies like DNA X, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Lytton Laurence W · Sole voting: 61,633 · Shared voting: 38,888 · Sole dispositive: 61,633 · Shared dispositive: 38,888 · SCHEDULE 13G/A, 2026-08-13
- · Holder: Lytton Laurence W · Percent: 8.1% · SCHEDULE 13G/A
- · Holder: DNA Holdings Venture Inc. · Percent: 19.9% · SCHEDULE 13D
- · Holder: Lytton Laurence W · Percent: 9.96% · SCHEDULE 13G/A
- · Holder: 1 Main Capital Management, LLC · Percent: 0% · SCHEDULE 13G/A
DNA X, Inc. has 16 Schedule 13D or 13G filings on record since 2025-07-02. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| DNA Holdings Venture Inc. | 19.9% | 223,201 | SCHEDULE 13D, 2026-02-20 | 2025-12-15 |
| 6.8% | 100,521 | SCHEDULE 13G/A, 2026-08-13 | 2026-06-30 | |
| CVI Investments, Inc. | 0% | 0 | SCHEDULE 13G/A, 2025-11-07 | 2025-09-30 |
| L1 Capital Global Opportunities Master Fund, Ltd. | 0% | 0 | SCHEDULE 13G/A, 2025-11-14 | 2025-11-14 |
| 1 Main Capital Management, LLC | 0% | 0 | SCHEDULE 13G/A, 2026-02-17 | 2025-12-31 |
| Streeterville Capital LLC | 0% | 0 | SCHEDULE 13G/A, 2026-01-23 |
Holding shares or following this stake? See who's behind DNA X, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on DNA X, Inc. and the records around it.
DNA X, Inc. elsewhere on the record
- Acquisition Dec 2025
- Who owns it
Companies that share a holder
- LYTTON LAURENCE W also filed stake reports on 28 other companies: Retension Pharmaceuticals, Inc. (Oct 2026), Rank One Computing Corp (Aug 2026), MDxHealth SA (Aug 2026)
- Streeterville Capital LLC also filed stake reports on 29 other companies: Professional Diversity Network, Inc. (Oct 2026), Solowin Holdings, Ltd. (Oct 2026), Vivos Therapeutics, Inc. (Sep 2026)
- L1 Capital Global Opportunities Master Fund, Ltd. also filed stake reports on 42 other companies: Youlife Group Inc. (Nov 2026), INLIF Ltd (Oct 2026), DarkIris Inc. (Oct 2026)
Watch DNA X, Inc.
Get an email when DNA X, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on DNA X, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on DNA X, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on DNA X, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Lytton Laurence W | 61,633 | 38,888 | 61,633 | 38,888 | SCHEDULE 13G/A, 2026-08-13 |
The latest filing identifies DNA X, Inc. by CUSIP 83548F309 and gives its principal executive office as 4445 EASTGATE MALL, SUITE 200, SAN DIEGO, CA 92121 (SCHEDULE 13G/A, 2026-08-13).
Purpose of Transaction (Item 4)
DNA Holdings Venture Inc.
The information set forth in or incorporated by reference in Item 3 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 4. Under the Membership Interest Purchase Agreement, DNA Holdings also agreed to vote all shares of the Issuer's common stock beneficially owned by DNA Holdings in favor of the asset purchase agreement, dated July 17, 2025, as subsequently amended and as amended from time to time, by and among the Issuer, Pace Car Acquisition LLC, the seller representative named in the asset purchase agreement, and Social Mobile Technology Holdings LLC (the "Asset Purchase Agreement") and granted the officers and directors of the Issuer irrevocable proxy to vote for the adoption of the Asset Purchase Agreement and against any proposal made in opposition to, or in competition with, the consummation of the Asset Purchase Agreement until the earlier of January 15, 2026 and the termination of the Asset Purchase Agreement. Pursuant to the Membership Interest Purchase Agreement, so long as DNA Holdings, directly or indirectly, beneficially owns at least 5% of the Issuer's outstanding common stock, DNA Holdings will have the right under the Membership Interest Purchase Agreement to designate one officer and one nominee for election to the Issuer's board of directors, and the Issuer will be required to take reasonably necessary corporate action to appoint such designees, subject to the oversight of the Issuer's nominating and governance …The first part of Item 4 of the SCHEDULE 13D filed 2026-02-20; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-02 | Lytton Laurence W | 11.2% | SCHEDULE 13G/A |
| 2025-07-03 | CVI Investments, Inc. | 7.3% | SCHEDULE 13G |
| 2025-07-07 | L1 Capital Global Opportunities Master Fund, Ltd. | 7.28% | SCHEDULE 13G |
| 2025-07-09 | Lytton Laurence W | 5.6% | SCHEDULE 13G/A |
| 2025-09-04 | 1 Main Capital Management, LLC | 5.1% | SCHEDULE 13G |
| 2025-11-07 | CVI Investments, Inc. | 0% | SCHEDULE 13G/A |
| 2025-11-14 | Lytton Laurence W | 7.8% | SCHEDULE 13G/A |
| 2025-11-14 | L1 Capital Global Opportunities Master Fund, Ltd. | 0% | SCHEDULE 13G/A |
| 2025-11-14 | 1 Main Capital Management, LLC | 8.2% | SCHEDULE 13G/A |
| 2025-12-18 | Streeterville Capital LLC | 9.9% | SCHEDULE 13G |
| 2026-01-23 | Streeterville Capital LLC | 0% | SCHEDULE 13G/A |
| 2026-02-17 | Lytton Laurence W | 9.96% | SCHEDULE 13G/A |
| 2026-02-17 | 1 Main Capital Management, LLC | 0% | SCHEDULE 13G/A |
| 2026-02-20 | DNA Holdings Venture Inc. | 19.9% | SCHEDULE 13D |
| 2026-05-15 | Lytton Laurence W | 8.1% | SCHEDULE 13G/A |
| 2026-08-13 | Lytton Laurence W | 6.8% | SCHEDULE 13G/A |
Questions about who owns DNA X, Inc.
Who owns DNA X, Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of DNA X, Inc.: DNA Holdings Venture Inc. (19.9%, Schedule 13D, filed 2026-02-20) and Lytton Laurence W (6.8%, Schedule 13G/A, filed 2026-08-13).
Who are the largest shareholders of DNA X, Inc.?
By the share each holder's latest filing reports, the largest holders of DNA X, Inc. on this page are DNA Holdings Venture Inc. (19.9%) and Lytton Laurence W (6.8%).
When did DNA Holdings Venture Inc. buy into DNA X, Inc.?
The filings give report dates, not purchase dates. The earliest filing from DNA Holdings Venture Inc. on this page is the Schedule 13D, filed 2026-02-20, reporting 19.9%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 16 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for DNA X, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| December 15, 2025 | Acquired DNA X LLC | $1.20M | Acquisition | Source |
Tools for this story
Each opens in a new tab, filled in for DNA X, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.